ADVERTISEMENT
Podcasts
Michiel van de Sande, MD, on a Multidisciplinary Approach to Treating TGCT
03/30/2020
Michiel Van de Sande, MD, PhD, Leiden University Medical Center, Leiden, Netherlands, shares how treating tenosynovial giant cell tumors (TGCT) therapy has evolved in the past 15 years, and walks through outcomes for surgery, radiotherapy, and pharmacotherapy.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement